{"id":481589,"title":"Qualifying notice for Rybrevant - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T17:02:44.935000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-rybrevant-254440.html?wbdisable=true","snippet":"Qualifying notice for Rybrevant Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney’s Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-e245921 Control #: 254440 [employee name removed] [employee title removed] Janssen Inc. 19…","rawSnapshotUrl":"/api/snapshots/raw/481589","browseUrl":"https://replay.healtharchive.ca/job-6/20260106170244/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-rybrevant-254440.html?wbdisable=true#ha_snapshot=481589","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}